Nature Search

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients

Xiaodan Meng
Simon A Joosse
Heidi Schwarzenbach
ResearchOpen Access22 Sept 2015
British Journal of Cancer

Volume: 113, P: 1358-1366
Clinical relevance of circulating cell-free microRNAs in cancer

The discovery of miRNAs in body fluids has opened up the possibility of using them as non-invasive biomarkers in cancer detection and as predictors of therapy response in cancer treatment. This Review article considers the latest developments in the use of circulating microRNAs as prognostic and predictive biomarkers and discusses their utility in personalized medicine.

Heidi Schwarzenbach
Naohiro Nishida
Klaus Pantel
Reviews04 Feb 2014
Nature Reviews Clinical Oncology

Volume: 11, P: 145-156
Cell-free nucleic acids as biomarkers in cancer patients

DNA, mRNA and microRNA are released and circulate in the blood of cancer patients. This Review discusses the potential clinical utility of cell-free nucleic acids as blood biomarkers.

Heidi Schwarzenbach
Dave S. B. Hoon
Klaus Pantel
Reviews12 May 2011
Nature Reviews Cancer

Volume: 11, P: 426-437
Author Correction: Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients

Qingtao Ni
Ines Stevic
Heidi Schwarzenbach
Amendments and CorrectionsOpen Access05 Dec 2019
Scientific Reports

Volume: 9, P: 1
Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients

Qingtao Ni
Ines Stevic
Heidi Schwarzenbach
ResearchOpen Access28 Aug 2018
Scientific Reports

Volume: 8, P: 1-10
Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy

Armin Soave
Lan Kluwe
Heidi Schwarzenbach
ResearchOpen Access09 Dec 2020
Scientific Reports

Volume: 10, P: 1-13

Quick links

Search

Filter By:

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients

Clinical relevance of circulating cell-free microRNAs in cancer

Cell-free nucleic acids as biomarkers in cancer patients

Author Correction: Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients

Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients

Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy

Search

Quick links